U.S. inflation has stayed above 2% for over 65 consecutive months, one of the longest stretches in modern history, with consumers increasingly accepting high inflation as the new normal. This shift in mindset worries Federal Reserve officials, as entrenched inflation expectations could weaken the impact of monetary policy tools like interest rate hikes. The persistent inflation is eroding purchasing power and influencing consumer behavior, potentially affecting economic growth and political outcomes. The Fed continues to monitor inflation closely, aiming to cool price growth without triggering a recession.
U.S. inflation remaining high is the subject, with Pluang market data as of Oct 15, 2026 00:22 WIB. For readers following U.S. stocks, here is Pluang's market snapshot: out of 150 priced US stocks tradable on Pluang, 39 rose and 111 fell today. Notable movers include FuelCell Energy Inc (FCEL) at USD 14.28 with a 1-day change of -7.87% and a Pluang order activity of 20% Sell / 80% Buy, SoFi Technologies Inc (SOFI) at USD 14.05 with a 1-day change of -7.81%, and Plug Power Inc (PLUG) at USD 1.45 with a 1-day change of -7.37%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
